Condition
Vitreoretinal Surgeries
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03413371Not ApplicableCompletedPrimary
Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)
NCT06501352Early Phase 1CompletedPrimary
Comparative Study Between Dexmedetomidine & Neostigmine as an Adjuvant to Local Anesthetic Mixture in Peribulbar Block in Vitreoretinal Surgeries
NCT03389243Not ApplicableCompletedPrimary
Paracetamol and Metamizole With SPI-guided Anaesthesia for VRS
NCT02973581Not ApplicableCompletedPrimary
SPI-directed Analgesia for Vitreoretinal Surgeries
Showing all 4 trials